1 deck published between 2019-07-31 and 2019-07-31 — 61 pages, 61 analysed slides total.
Each deck in chronological order — click to open. This is the story of the campaign as it unfolded.
Penumbra is a commoditized single-product 510(k) company whose aspiration-catheter franchise is collapsing to deep-pocketed bundlers; Spruce Point sees 40-55% downside to $85-110 per share.